What Happened?
San Diego, CA-based Organovo has promoted Sharon Collins Presnell as Chief Technical Officer.
About the Company
Organovo (NYSE MKT: ONVO) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The Company is collaborating with pharmaceutical and academic partners to develop human biological disease models in three dimensions. These 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost. In addition to numerous scientific publications, their technology has been featured in The Wall Street Journal, Time Magazine, The Economist, and other outlets. Organovo is changing the shape of medical research and practice.
About the Person
Previously Presnell was Executive Vice President of Research and Development at Organovo.
Info Source
News
Short Profile